Xenon ameliorates chronic post-surgical pain by regulating mitophagy in microglia and rats mediated by PINK1/Parkin

Hu Lv1,2, Jiaojiao Huang1,2, Xin Zhang1,2

  • 1Department of Anesthesiology, Fudan University Shanghai Cancer Center, Shanghai, China.

Peerj
|February 23, 2024
PubMed
Abstract

Insights

Xenon (Xe) inhalation alleviates chronic post-surgical pain (CPSP) by reducing spinal cord microglial activation and oxidative stress. This effect is mediated through the PINK1/Parkin pathway, promoting microglial mitophagy.

Area of Science:

  • Neuroscience
  • Anesthesiology
  • Pain Management

Background:

  • Chronic post-surgical pain (CPSP) significantly impacts patient recovery.
  • Microglial activation in the spinal cord is a key factor in CPSP development and maintenance.
  • The precise mechanism by which xenon (Xe), an anesthetic gas, modulates microglial activity in CPSP is not fully understood.

Purpose of the Study:

  • To investigate the therapeutic potential of xenon in a rat model of chronic post-surgical pain (CPSP).
  • To elucidate the underlying mechanisms of xenon's action, focusing on microglial activation, oxidative stress, and mitophagy.
  • To explore the role of the PINK1/Parkin signaling pathway in xenon's analgesic effects.

Main Methods:

  • Establishment of a CPSP rat model using skin/muscle incision and retraction (SMIR).
  • Treatment with 50% xenon (Xe) inhalation for 1 hour daily for 5 consecutive days.
  • Assessment of pain behaviors (PWMT, TWL), microglial activation (Iba1), oxidative stress markers (MDA, SOD, H2O2, CAT), mitophagy markers (Mito-Tracker, LC3), and the PINK1/Parkin pathway.

Main Results:

  • Xenon treatment significantly improved pain behaviors (PWMT and TWL) in the CPSP rat model.
  • Xe inhalation reduced microglial activation and oxidative stress in the spinal dorsal horn.
  • Xe promoted microglial mitophagy and activated the PINK1/Parkin signaling pathway, as evidenced by increased autophagy markers and protein expression.

Conclusions:

  • Xenon effectively ameliorates chronic post-surgical pain in rats.
  • The analgesic effects of xenon are attributed to the regulation of microglial mitophagy via the PINK1/Parkin pathway.
  • Xenon presents a promising therapeutic target for preventing and treating CPSP.